Skip to content

Clinical trials

Completed Vitreoretinopathy, Proliferative trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vitreoretinopathy, Proliferative Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20101
20111
20121
20131
20151
20192
20201
20213
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wills Eye2
Ahalia Foundation Eye Hospital1
Aldeyra Therapeutics, Inc.1
Alexandria University1
Anggun Rama Yudantha1
Benha University1
Cairo University1
Central Hospital, Nancy, France1
Centro Oftalmológico Dr Charles1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vitreoretinopathy, Proliferative17
Retinal Detachment12
Camurati-Engelmann Syndrome1
Diabetic Retinopathy1
Retinoschisis1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.